Biotechnology at Ursuline College

Ohio's biotechnology sector offers opportunities in pharmaceuticals and medical devices, but the estimated numbers here—$47,000 in first-year earnings against $24,125 in debt—tell a qualified success story. That debt-to-earnings ratio of 0.51 sits in reasonable territory, suggesting graduates from similar programs can typically manage their loans while establishing careers. However, with only three schools offering biotechnology bachelor's programs in Ohio and none reporting actual outcomes data, you're working with limited visibility into how this field performs specifically in the state.

The estimated earnings align almost exactly with the national median for biotechnology bachelor's programs, which provides some reassurance that comparable programs generally produce consistent outcomes. The debt figure runs slightly higher than the national median of $20,618, though not dramatically so. What's harder to assess is career trajectory: biotechnology can require graduate education for advancement into research roles, potentially adding years and debt before reaching higher earnings potential. For students planning to work immediately after the bachelor's degree—perhaps in quality control, lab tech positions, or pharmaceutical sales—these numbers represent a workable starting point.

Given Ursuline's high admission rate and the fact that 39% of students receive Pell grants, this program may serve students who need an affordable entry into the life sciences. Just understand you're betting on peer program performance rather than this school's proven track record, and factor in whether your child's career goals require stopping at the bachelor's level or continuing to graduate school.